PURPOSE: The National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is a library of question items that enables patient reporting of adverse events (AEs) in clinical trials. This study contributes content validity evidence of the PRO-CTCAE by incorporating cancer patient input of the relevance and comprehensiveness of the item library. METHODS: Cognitive interviews were conducted among patients undergoing chemotherapy or radiation therapy at multiple sites to evaluate comprehension, memory retrieval, judgment, and response mapping related to AE terms (e.g., nausea), attribute terms (regarding frequency, severity, or interference), response options, and recall period. Three interview rounds were conducted with ≥20 patients completing each item per round. Items were modified and retested if ≥3 patients exhibited cognitive difficulties or if experienced by ≤25% patients. RESULTS: One hundred and twenty-seven patients participated (35% ≤high school, 28% non-white, and 59% female). Most AE terms (63/80) generated no cognitive difficulties. The remaining 17 were modified without further difficulties by Round 3. Terms were comprehended regardless of education level. Attribute terms and response options required no modifications. Patient adherence to recall period (7 days) was improved when the reference period was incorporated. CONCLUSIONS: This study provides evidence confirming comprehension of the US English language versions of items in the PRO-CTCAE library for measuring symptomatic AEs from the patient perspective within the context of cancer treatment. Several minor changes were made to the items to improve item clarity, comprehension, and ease of response judgment. This study helps to establish the content validity of PRO-CTCAE items for patient reporting of AEs during cancer treatment.
PURPOSE: The National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is a library of question items that enables patient reporting of adverse events (AEs) in clinical trials. This study contributes content validity evidence of the PRO-CTCAE by incorporating cancerpatient input of the relevance and comprehensiveness of the item library. METHODS: Cognitive interviews were conducted among patients undergoing chemotherapy or radiation therapy at multiple sites to evaluate comprehension, memory retrieval, judgment, and response mapping related to AE terms (e.g., nausea), attribute terms (regarding frequency, severity, or interference), response options, and recall period. Three interview rounds were conducted with ≥20 patients completing each item per round. Items were modified and retested if ≥3 patients exhibited cognitive difficulties or if experienced by ≤25% patients. RESULTS: One hundred and twenty-seven patients participated (35% ≤high school, 28% non-white, and 59% female). Most AE terms (63/80) generated no cognitive difficulties. The remaining 17 were modified without further difficulties by Round 3. Terms were comprehended regardless of education level. Attribute terms and response options required no modifications. Patient adherence to recall period (7 days) was improved when the reference period was incorporated. CONCLUSIONS: This study provides evidence confirming comprehension of the US English language versions of items in the PRO-CTCAE library for measuring symptomatic AEs from the patient perspective within the context of cancer treatment. Several minor changes were made to the items to improve item clarity, comprehension, and ease of response judgment. This study helps to establish the content validity of PRO-CTCAE items for patient reporting of AEs during cancer treatment.
Authors: Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring Journal: Value Health Date: 2011-10-10 Impact factor: 5.725
Authors: Chantal Quinten; John Maringwa; Carolyn C Gotay; Francesca Martinelli; Corneel Coens; Bryce B Reeve; Henning Flechtner; Eva Greimel; Madeleine King; David Osoba; Charles Cleeland; Jolie Ringash; Joseph Schmucker-Von Koch; Martin J B Taphoorn; Joachim Weis; Andrew Bottomley Journal: J Natl Cancer Inst Date: 2011-12-07 Impact factor: 13.506
Authors: Ethan M Basch; Bryce B Reeve; Sandra A Mitchell; Stephen B Clauser; Lori Minasian; Laura Sit; Ram Chilukuri; Paul Baumgartner; Lauren Rogak; Emily Blauel; Amy P Abernethy; Deborah Bruner Journal: Cancer J Date: 2011 Jul-Aug Impact factor: 3.360
Authors: Elfriede R Greimel; Vesna Bjelic-Radisic; Jacobus Pfisterer; Felix Hilpert; Fedor Daghofer; Eric Pujade-Lauraine; Andreas du Bois Journal: Support Care Cancer Date: 2010-08-06 Impact factor: 3.603
Authors: Brooke Tang; Meredith Giuliani; Lisa W Le; Jane Higgins; Andrea Bezjak; Anthony Brade; B C John Cho; Alexander Sun; Andrew J Hope Journal: Clin Lung Cancer Date: 2012-08-11 Impact factor: 4.785
Authors: Jordanka Kirkova; Mellar P Davis; Declan Walsh; Eoin Tiernan; Norma O'Leary; Susan B LeGrand; Ruth L Lagman; K Mitchell Russell Journal: J Clin Oncol Date: 2006-03-20 Impact factor: 44.544
Authors: L Ashley; H Jones; J Thomas; D Forman; A Newsham; E Morris; O Johnson; G Velikova; P Wright Journal: Br J Cancer Date: 2011-11-08 Impact factor: 7.640
Authors: Thomas M Atkinson; Charissa F Andreotti; Kailey E Roberts; Rebecca M Saracino; Marisol Hernandez; Ethan Basch Journal: Support Care Cancer Date: 2015-08-28 Impact factor: 3.603
Authors: Amylou C Dueck; Tito R Mendoza; Sandra A Mitchell; Bryce B Reeve; Kathleen M Castro; Lauren J Rogak; Thomas M Atkinson; Antonia V Bennett; Andrea M Denicoff; Ann M O'Mara; Yuelin Li; Steven B Clauser; Donna M Bryant; James D Bearden; Theresa A Gillis; Jay K Harness; Robert D Siegel; Diane B Paul; Charles S Cleeland; Deborah Schrag; Jeff A Sloan; Amy P Abernethy; Deborah W Bruner; Lori M Minasian; Ethan Basch Journal: JAMA Oncol Date: 2015-11 Impact factor: 31.777
Authors: Ashley Leak Bryant; Erin Coffman; Brett Phillips; Xianming Tan; Elizabeth Bullard; Rachel Hirschey; Joshua Bradley; Antonia V Bennett; Angela M Stover; Lixin Song; Thomas C Shea; William A Wood Journal: Support Care Cancer Date: 2019-06-20 Impact factor: 3.603
Authors: Wan-Shui Wu; Jing-Jing Liu; Yan-Ling Sun; Shu-Xu DU; Chun-De Li; Miao Li; Si-Qi Ren; Jin Zhang; Xiao-Jun Gong; Li-Ming Sun Journal: Zhongguo Dang Dai Er Ke Za Zhi Date: 2019-12
Authors: Ethan Basch; Bryce B Reeve; Sandra A Mitchell; Steven B Clauser; Lori M Minasian; Amylou C Dueck; Tito R Mendoza; Jennifer Hay; Thomas M Atkinson; Amy P Abernethy; Deborah W Bruner; Charles S Cleeland; Jeff A Sloan; Ram Chilukuri; Paul Baumgartner; Andrea Denicoff; Diane St Germain; Ann M O'Mara; Alice Chen; Joseph Kelaghan; Antonia V Bennett; Laura Sit; Lauren Rogak; Allison Barz; Diane B Paul; Deborah Schrag Journal: J Natl Cancer Inst Date: 2014-09-29 Impact factor: 13.506
Authors: Thomas M Atkinson; Jennifer L Hay; Alexander Shoushtari; Yuelin Li; Daniel J Paucar; Sloane C Smith; Ragini R Kudchadkar; Austin Doyle; Jeffrey A Sosman; Jorge Fernando Quevedo; Mohammed M Milhem; Anthony M Joshua; Gerald P Linette; Thomas F Gajewski; Jose Lutzky; David H Lawson; Christopher D Lao; Patrick J Flynn; Mark R Albertini; Takami Sato; Karl Lewis; Brian Marr; David H Abramson; Mark Andrew Dickson; Gary K Schwartz; Richard D Carvajal Journal: J Cancer Res Clin Oncol Date: 2016-12-05 Impact factor: 4.553
Authors: Bryce B Reeve; Molly McFatrich; Laura C Pinheiro; David R Freyer; Ethan M Basch; Justin N Baker; Janice S Withycombe; Lillian Sung; Jennifer W Mack; Mia K Waldron; Catriona Mowbray; Diana Palma; Pamela S Hinds Journal: J Pain Symptom Manage Date: 2017-01-03 Impact factor: 3.612
Authors: Antonia V Bennett; Bryce B Reeve; Ethan M Basch; Sandra A Mitchell; Mathew Meeneghan; Claudio L Battaglini; Abbie E Smith-Ryan; Brett Phillips; Thomas C Shea; William A Wood Journal: Qual Life Res Date: 2015-11-17 Impact factor: 4.147